{"id":"W2332561578","doi":"10.1158/1538-7445.am2011-2242","title":"Abstract 2242: A randomized phase 2 study of the cyclin-dependent kinase (CDK) inhibitor Dinaciclib (SCH 727965) in patients with non-small cell lung cancer (NSCLC)","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Cancer Foundation; Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Erlotinib; Internal medicine; Oncology; Lung cancer; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001354404,0.0003677038,0.001004275,0.0003900005,0.0001648135,0.00002438553,0.000546972,0.0001259585,0.0007231013],"category_scores_gemma":[0.000133696,0.0002263736,0.0001547894,0.0009170373,0.0005066966,0.0001914288,0.0002494169,0.001167318,0.000007696131],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007798997,"about_ca_system_score_gemma":0.0009624697,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008110246,"about_ca_topic_score_gemma":0.001937145,"domain_scores_codex":[0.9957128,0.0004183924,0.0007529001,0.0007201032,0.001532054,0.000863754],"domain_scores_gemma":[0.9973046,0.0002813141,0.0003248469,0.0009751073,0.0008431598,0.0002709793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.368388,0.01035339,0.5767279,0.0007757358,0.0005284897,0.0001162505,0.01696697,0.0001006987,0.01400059,0.000008655019,0.0001176173,0.01191566],"study_design_scores_gemma":[0.5985436,0.001789561,0.3217152,0.001882352,0.0002787209,0.000001623766,0.00360809,0.00005235955,0.07155856,0.0000422303,0.00009373029,0.0004339743],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896937,0.001558636,0.00001970808,0.0001383992,0.0002947481,0.007194531,0.00006661883,0.00002946982,0.001004212],"genre_scores_gemma":[0.9963182,0.0001707272,0.00008333228,0.00006837576,0.0001986277,0.002512027,0.000005813572,0.0001002537,0.0005426005],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2550128,"threshold_uncertainty_score":0.9984949,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04515505282875971,"score_gpt":0.3741909476857539,"score_spread":0.3290358948569942,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}